A regulatory filing disclosed that GluMetrics has obtained more than $3 million in a funding round aiming for $6 million. The California-based company is the maker of the GluCath system, a single-use intravascular device that combines a sensor and catheter to monitor glucose levels in ICU patients continuously.

Full Story:

Related Summaries